The Leukemia Lymphoma Society
The Leukemia Lymphoma Society is the largest voluntary health organization this dedicated to supporting the fight against blood cancers. They fund blood cancer research, education and patient services. The leukemia lymphoma society mission is to cure leukemia, lymphoma, Hodgkin’s disease and even myeloma. As this is happening they seek to improve the quality of life of patients and their families. Since the first funding of the leukemia lymphoma society in 1954, the society has awarded more than $680 million in research dollars.
The Leukemia Lymphoma society was created out of a single family’s grief following the death of their teenage son. Robert Roesler de Villiers was son of a richNew York family and was only 16 when he quickly die of leukemia in 1944. Five years later, his parents Rudolph and Antoinette de Villiers started a fundraising and education organization. At first it was headquartered in a small Wall Street office and the Robert Roesler de Villiers Foundation had only a few volunteers and a tiny budget. Most leukemia patients died within three months. Even when the first generation chemotherapy drugs began appearing in the mid 1950s, the disease remained a stubborn challenge.
Driven by the belief that leukemia and other blood cancers are indeed curable, the early leukemia lymphoma society grew steadily, opening its first chapters in New York City. The organization was renamed The Leukemia Society of America in the 1960s to communicate a broad, national reach. Increased funding from generous donors allowed the leukemia lymphoma society to identify promising young researchers and help support their work.
The Leukemia and Lymphoma Society changed its name from the Leukemia Society of America in 2000 to reflect its commitment to curing all different types of blood cancers. The leukemia lymphoma society is proud to be playing a major role in the battle against leukemia, lymphoma and myeloma. With the help of major fundraising campaigns, such as Team In Training, the world’s largest sports training program, the leukemia lymphoma society has awarded more than $600 million in research funding.
The commitment to cutting-edge science for lymphoma leukemia has contributed to an unprecedented rise in survival rates for many blood cancers. The relative five-year survival rate for people with with the blood cancer leukemia, for example, nearly increase four time in the past 48 years. Hodgkins lymphoma is now considered to be one of the most curable forms of cancer. This is thanks to research in radiation, chemotherapy and a combination of the two. Supporting the leukemia lymphoma society will help to eradicate blood cancers all over the world.